BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 20272216)

  • 1. Suppression of treponemicidal action of arsenic with 2,3-dimercaptopropanol (BAL) report of clinical observations in five cases.
    De OREO GA
    Arch Derm Syphilol; 1947 Nov; 56(5):695-8. PubMed ID: 20272216
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical uses of 2,3-dimercaptopropanol (BAL); the effect of BAL on the excretion of arsenic in arsenical intoxication.
    LUETSCHER JA; EAGLE H; LONG-COPE WT
    J Clin Invest; 1946 Jul; 25(4):534-40. PubMed ID: 21001627
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical uses of 2,3-dimercaptopropanol (BAL); the treatment of arsenical dermatitis with preparations of BAL.
    LONGCOPE WT; LUETSCHER JA
    J Clin Invest; 1946 Jul; 25(4):528-33. PubMed ID: 21001626
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical uses of 2,2-dimercaptopropanol (BAL); the systemic treatment of experimental arsenic poisoning (mapharsen, lewisite, phenyl arsenoxide) with BAL.
    EAGLE H; MAGNUSON HJ; FLEISCHMAN R
    J Clin Invest; 1946 Jul; 25(4):451-66. PubMed ID: 21001620
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of 2,3-dimercaptopropanol (BAL) on the whole blood and plasma concentration of arsenic after mapharsen in cats.
    RIKER WF; ROSENFELD G
    J Pharmacol Exp Ther; 1946 Aug; 87(4 Suppl):72-5. PubMed ID: 20275115
    [No Abstract]   [Full Text] [Related]  

  • 6. An adverse effect of BAL in a case of subacute arsenical polyneuritis, with observations on porphyrin metabolism.
    SANDS JH; BERRIS B; SCHERER LR
    N Engl J Med; 1950 Oct; 243(15):558-61. PubMed ID: 14780333
    [No Abstract]   [Full Text] [Related]  

  • 7. The fate of arsenical vesicants in the skin and the effect of BAL (British anti-lewisite).
    Graham AF; Levvy GA; Chance AC
    Biochem J; 1947; 41(3):352-7. PubMed ID: 16748172
    [No Abstract]   [Full Text] [Related]  

  • 8. British anti-lewisite; a report on its use and therapeutic value in arsenical intoxications, from the BAL Conference, Medical Research Council.
    PETERS RA; BENNET J
    Br Med J; 1947 Oct; 2(4526):520. PubMed ID: 20267003
    [No Abstract]   [Full Text] [Related]  

  • 9. The treatment by 2,3-dimercaptopropanol (BAL) of the systemic toxic effects of skin contamination with lewisite and phenyldichlorarsine.
    HARRISON HE; DURLACHER SH
    J Pharmacol Exp Ther; 1946 Aug; 87(4 Suppl):81-4. PubMed ID: 20275117
    [No Abstract]   [Full Text] [Related]  

  • 10. [Two cases of severe arsenical erythroderma, successfully treated with the new BAL compound].
    NOGUER-MORE
    Actas Dermosifiliogr; 1948 Jan; 39(4):498-507. PubMed ID: 18865721
    [No Abstract]   [Full Text] [Related]  

  • 11. Poisoning from inhalation of the vapors of lewisite and phenyldichlorarsine; its pathology in the dog and treatment with 2,3-dimercaptopropanol (BAL).
    HARRISON HE; ORDWAY NK
    J Pharmacol Exp Ther; 1946 Aug; 87(4 Suppl):76-80. PubMed ID: 20275116
    [No Abstract]   [Full Text] [Related]  

  • 12. [BAL in the treatment of intoxication by arsenical and gold preparations].
    BERMUDEZ ABREU VP
    Rev Kuba Med Trop Parasitol; 1950; 6(3-4):59-65. PubMed ID: 15441436
    [No Abstract]   [Full Text] [Related]  

  • 13. [B.A.L treatment of arsenical poisoning].
    MIGNOLET F; HEUSGHEM C; BACQ ZM
    Acta Clin Belg; 1947; 2():199-204. PubMed ID: 20269203
    [No Abstract]   [Full Text] [Related]  

  • 14. Condensation of 2,3-dimercaptopropanol with oxophenarsine hydrochloride; toxicity and chemotherapeutic effect.
    SAWYERS JL; BURROWS B; MAREN TH
    Proc Soc Exp Biol Med; 1949 Feb; 70(2):194-7. PubMed ID: 18112762
    [No Abstract]   [Full Text] [Related]  

  • 15. The treatment of arsenical dermatitis with dimercaptopropanol (BAL).
    CARLETON AB; PETERS RA; THOMPSON RH
    Q J Med; 1948 Jan; 17(65):49-79. PubMed ID: 18905506
    [No Abstract]   [Full Text] [Related]  

  • 16. Arsenical encephalopathy treated with B. A. L.
    KONAR NR; DASS AK
    Calcutta Med J; 1950 Jun; 47(6):188-90. PubMed ID: 14772650
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of BAL in the treatment of arsenical neuropathy.
    MALHOTRA SL
    Ind Med Gaz; 1951 Aug; 86(8):340-3. PubMed ID: 14888288
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of BAL (2,3 dimercaptopropanol) in arsenical encephalopathy.
    DANBY CW
    Can Med Assoc J; 1948 Mar; 58(3):284. PubMed ID: 18906656
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical uses of 2,3-dimercaptopropanol (BAL); the treatment of lewisite burns of the eye with BAL.
    HUGHES WF
    J Clin Invest; 1946 Jul; 25(4):541-8. PubMed ID: 21001628
    [No Abstract]   [Full Text] [Related]  

  • 20. [Poisoning with arsenical gases and heavy metals and the possibility of their treatment].
    POPOVIC V
    Vojnosanit Pregl; 1951; 8(1-2):35-8. PubMed ID: 14836470
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.